- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the safety, pharmacokinetics (PK), pharmacodynamics (PD), and exploratory efficacy of GZ402671 / SAR402671 in enzyme replacement therapy treatment-naïve adult male patients diagnosed with Fabry disease.
Inclusion criteria
- Fabry Disease